+ All Categories
Home > Documents > Introduction ACS

Introduction ACS

Date post: 05-Dec-2015
Category:
Upload: vivi-anggelia-ang
View: 228 times
Download: 0 times
Share this document with a friend
Description:
ACS
Popular Tags:
68
Yeo Hans Cahyadi Yeo Hans Cahyadi MD PhD MD PhD FESC FESC Born: Jakarta, 24 August 1955 Born: Jakarta, 24 August 1955 Status: Married, 3 children Status: Married, 3 children Education: High school, Budi Mulia, 1973 Education: High school, Budi Mulia, 1973 GP, University of Indonesia, 1980 GP, University of Indonesia, 1980 Cardiologist, Kanazawa Med University, Cardiologist, Kanazawa Med University, Japan,1991 Japan,1991 PhD, Kanazawa Medical University, Japan, 1991 PhD, Kanazawa Medical University, Japan, 1991 Fellow of European Society of Cardiology Fellow of European Society of Cardiology (FESC), 2007 (FESC), 2007 Employment: Employment: Primary Health Care, Kalimantan 1980-1984 Primary Health Care, Kalimantan 1980-1984 GP in Husada Hospital 1984-1986 GP in Husada Hospital 1984-1986 Cardiologist, Husada Hospital 1991-now Cardiologist, Husada Hospital 1991-now President Director of Husada Hospital 1999-2005 President Director of Husada Hospital 1999-2005 Head of Depart of Cardiology, Husada Hospital 1999-now Head of Depart of Cardiology, Husada Hospital 1999-now
Transcript
Page 1: Introduction ACS

Yeo Hans Cahyadi Yeo Hans Cahyadi MD PhDMD PhD FESC FESC

Born: Jakarta, 24 August 1955Born: Jakarta, 24 August 1955Status: Married, 3 childrenStatus: Married, 3 childrenEducation: High school, Budi Mulia, 1973Education: High school, Budi Mulia, 1973

GP, University of Indonesia, 1980 GP, University of Indonesia, 1980 Cardiologist, Kanazawa Med University, Japan,1991 Cardiologist, Kanazawa Med University, Japan,1991 PhD, Kanazawa Medical University, Japan, 1991PhD, Kanazawa Medical University, Japan, 1991

Fellow of European Society of Cardiology (FESC), 2007Fellow of European Society of Cardiology (FESC), 2007Employment:Employment:

Primary Health Care, Kalimantan 1980-1984Primary Health Care, Kalimantan 1980-1984 GP in Husada Hospital 1984-1986GP in Husada Hospital 1984-1986 Cardiologist, Husada Hospital 1991-now Cardiologist, Husada Hospital 1991-now President Director of Husada Hospital 1999-2005President Director of Husada Hospital 1999-2005 Head of Depart of Cardiology, Husada Hospital 1999-nowHead of Depart of Cardiology, Husada Hospital 1999-now

Page 2: Introduction ACS

Kegawatdaruratan Jatung Kegawatdaruratan Jatung Infark Miokard AkutInfark Miokard Akut

Dr. Yeo Hans Cahyadi PhD, SpJP, FIHA, FESCDr. Yeo Hans Cahyadi PhD, SpJP, FIHA, FESC

Page 3: Introduction ACS
Page 4: Introduction ACS
Page 5: Introduction ACS
Page 6: Introduction ACS
Page 7: Introduction ACS
Page 8: Introduction ACS
Page 9: Introduction ACS
Page 10: Introduction ACS
Page 11: Introduction ACS
Page 12: Introduction ACS
Page 13: Introduction ACS
Page 14: Introduction ACS
Page 15: Introduction ACS
Page 16: Introduction ACS
Page 17: Introduction ACS
Page 18: Introduction ACS
Page 19: Introduction ACS
Page 20: Introduction ACS
Page 21: Introduction ACS

Normal ECGNormal ECG

Page 22: Introduction ACS

VES (Ventricular Extra-Systole)VES (Ventricular Extra-Systole)

Page 23: Introduction ACS

VES (Ventricular Extra-systole)pada Old Antero-septal MI

Page 24: Introduction ACS

Anterior-inferior STEMI

Page 25: Introduction ACS

VT (Ventricular Tachycardia)

Page 26: Introduction ACS

Ventricular Fibrillation

Cardiac Arrest

Page 27: Introduction ACS

DefibrillatorDefibrillator

Page 28: Introduction ACS

ATHEROSCLEROSIS

INTRAPLAGUE THROMBUS

Page 29: Introduction ACS

PLAGUE RUPTURE

INTRALUMINAL THROBUS

Page 30: Introduction ACS

PLAGUE RUPTURE

PROPAGATION THROMBUS

Page 31: Introduction ACS

The Vulnerable Plaque

Page 32: Introduction ACS

Plaque Disruption

Page 33: Introduction ACS
Page 34: Introduction ACS

3434

1990199219941996199820002002

1990ACC/AHA

AMI R.

Gunnar

1994AHCPR/NHLBI

UA E. Braunwald 1996 1999

Rev Upd ACC/AHA AMI T. Ryan

2004 2007 Rev Upd ACC/AHA STEMI E. Antman

2000 2002 2007 Rev Upd RevACC/AHA UA/NSTEMI E. Braunwald; J. Anderson

20042007

Evolution of Guidelines for ACS

2009

2009Upd

ACC/AHA STEMI/PCIF. Kushner

Page 35: Introduction ACS

Pathway: Triage and Transfer for PCI (in STEMI)Pathway: Triage and Transfer for PCI (in STEMI)

2009 STEMI Focused Update. Appendix 5

STEMI patient who is acandidate for reperfusion

Initially seen at a PCIcapable facility

Initially seen at a non-PCIcapable facility

Send to Cath Lab for primary PCI(Class I, LOE:A)

Transfer for primary PCI(Class I, LOE:A)

Initial Treatmentwith fibrinolytictherapy (Class 1, LOE:A)

Prep antithrombotic (anticoagulantplus antiplatelet) regimen

Diagnostic angio

Medicaltherapy only

PCI CABG

NOT HIGH RISK

Transfer to a PCI facility may be considered (Class IIb, LOE:C), especially if ischemic symptoms persist and failure to reperfuse is suspected

HIGH RISKTransfer to a PCI facility is reasonable for early diagnostic angio & possible PCI or CABG (Class IIa, LOE:B),

High-risk patients as defined by 2007 STEMI Focused Update should undergo cath (Class 1: LOE B)

At PCI facility, evaluate for timing of diagnostic angio

Page 36: Introduction ACS
Page 37: Introduction ACS
Page 38: Introduction ACS
Page 39: Introduction ACS
Page 40: Introduction ACS

Mr. SS, 23-03-2011 (9 Ms post PCI)Mr. SS, 23-03-2011 (9 Ms post PCI)

Angina PectorisAngina Pectoris

Cardiogenic shock, BP 85/65 mmHgCardiogenic shock, BP 85/65 mmHg

ECGECG

Page 41: Introduction ACS

Mr. SS, ECG pre Primary PCI

Page 42: Introduction ACS

Mr. SS, CAG + Primary PCIMr. SS, CAG + Primary PCI

Page 43: Introduction ACS

Mr. SS, Primary PCIMr. SS, Primary PCI

Page 44: Introduction ACS

Mr. SS, ECG post Primary PCI

Page 45: Introduction ACS
Page 46: Introduction ACS
Page 47: Introduction ACS
Page 48: Introduction ACS
Page 49: Introduction ACS

Time is MoneyTime is Money

Page 50: Introduction ACS

Time is Time is MyocardiumMyocardium

Page 51: Introduction ACS
Page 52: Introduction ACS

Copyright restrictions may apply.Kim, K. P. et al. Arch Intern Med 2009;169:1188-1194.

Estimated lifetime risk of radiation-induced cancer per 100 000 persons from a single computed tomographic scan to assess coronary artery calcification by age at screening

Page 53: Introduction ACS

Copyright restrictions may apply.Kim, K. P. et al. Arch Intern Med 2009;169:1188-1194.

Site-Specific Estimates of the Lifetime Risk of Radiation-Induced Cancer From a Single Coronary Artery Calcification Computed Tomographic Screen at Age 55 Years

Page 54: Introduction ACS

Thank youThank you

Page 55: Introduction ACS
Page 56: Introduction ACS
Page 57: Introduction ACS
Page 58: Introduction ACS
Page 59: Introduction ACS
Page 60: Introduction ACS
Page 61: Introduction ACS
Page 62: Introduction ACS
Page 63: Introduction ACS
Page 64: Introduction ACS
Page 65: Introduction ACS
Page 66: Introduction ACS

6666

ACC/AHA 2009 STEMI/PCI Guidelines ACC/AHA 2009 STEMI/PCI Guidelines Focused Update Focused Update

Based on the ACC/AHA Guidelines for the Management of Patients With ST-Elevation

Myocardial Infarction (STEMI) and the ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (PCI): A Report of the ACC/AHA Task Force on Practice Guidelines

Page 67: Introduction ACS

6767

Class I Benefit >>> Risk

Procedure/ Treatment SHOULD be performed/ administered

Class IIa Benefit >> RiskAdditional studies with focused objectives needed

IT IS REASONABLE to perform procedure/administer treatment

Class IIb Benefit ≥ RiskAdditional studies with broad objectives needed; Additional registry data would be helpful

Procedure/Treatment MAY BE CONSIDERED

Class III Risk ≥ BenefitNo additional studies needed

Procedure/Treatment should NOT be performed/administered SINCE IT IS NOT HELPFUL AND MAY BE HARMFUL

shouldis recommendedis indicatedis useful/effective/

beneficial

is reasonablecan be useful/effective/

beneficialis probably recommended

or indicated

may/might be consideredmay/might be reasonableusefulness/effectiveness is

unknown /unclear/uncertain or not well established

is not recommendedis not indicatedshould notis not

useful/effective/beneficialmay be harmful

Applying Classification of Recommendations and Level of Evidence

Page 68: Introduction ACS

Class I Benefit >>> Risk

Procedure/ Treatment SHOULD be performed/ administered

Class IIa Benefit >> RiskAdditional studies with focused objectives needed

IT IS REASONABLE to perform procedure/administer treatment

Class IIb Benefit ≥ RiskAdditional studies with broad objectives needed; Additional registry data would be helpful

Procedure/Treatment MAY BE CONSIDERED

Class III Risk ≥ BenefitNo additional studies needed

Procedure/Treatment should NOT be performed/administered SINCE IT IS NOT HELPFUL AND MAY BE HARMFUL

Applying Classification of Recommendations and Level of Evidence

Level A: Multiple populations evaluated; Data derived from multiple randomized clinical trials or meta-analyses

Level B: Limited populations evaluated. Data derived from a single randomized trial or non-randomized studies

Level C: Very limited populations evaluated. Only consensus opinion of experts, case studies, or standard-of-care.


Recommended